相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
BRITISH JOURNAL OF NUTRITION (2014)
Resveratrol modulates autophagy and NF-kappa B activity in a murine model for treating non-alcoholic fatty liver disease
Lake Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients
Faezeh Askari et al.
NUTRITION RESEARCH (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
S. Bo et al.
CURRENT MEDICINAL CHEMISTRY (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
S. Gomez-Zorita et al.
BRITISH JOURNAL OF NUTRITION (2012)
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
Su-Jung Cho et al.
BRITISH JOURNAL OF NUTRITION (2012)
Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
Jun Yoshino et al.
CELL METABOLISM (2012)
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Jill P. Crandall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
Improving Glucose Metabolism With Resveratrol in a Swine Model of Metabolic Syndrome Through Alteration of Signaling Pathways in the Liver and Skeletal Muscle
Thomas A. Burgess et al.
ARCHIVES OF SURGERY (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Resveratrol Improves Insulin Resistance Hyperglycemia and Hepatosteatosis But Not Hypertriglyceridemia, Inflammation, and Life Span in a Mouse Model for Werner Syndrome
Adam Labbe et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Nonalcoholic Fatty Liver Disease
Kathryn Law et al.
CLINICS IN LIVER DISEASE (2010)
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
Maria Cristina Elias et al.
NUTRITION (2010)
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
Leonor Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Non-alcoholic fatty liver disease pathogenesis: The present and the future
S. Petta et al.
DIGESTIVE AND LIVER DISEASE (2009)
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
Jing Shang et al.
ACTA PHARMACOLOGICA SINICA (2008)
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Luis Bujanda et al.
BMC GASTROENTEROLOGY (2008)
GI Epidemiology: nonalcoholic fatty liver disease
P. Angulo
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Compendium of Physical Activities: an update of activity codes and MET intensities
BE Ainsworth et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2000)